- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 134.87M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $2.09B |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $53.37M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $1.46B |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $537M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.04B |
| Current Assets | FY 2024 · Dec 31, 2023 | $649.02M |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.51B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 138.99M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $13.99M |
| Capex | FY 2024 · Dec 31, 2022 | $391.42M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $373.87M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $0.33 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $0.47 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $324.81M |
| Net Income | FY 2024 · Dec 31, 2022 | $69.32M |
| Operating Income | FY 2024 · Dec 31, 2022 | $190.41M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $2.39B |
| Revenue | FY 2024 · Dec 31, 2022 | $2.97B |